A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia
Clinical trial NCT01055483 · COMPLETED
Trial details
- NCT number
- NCT01055483
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2012-02-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.